Related Experiment Video
Updated: Jun 20, 2026

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells
Published on: March 28, 2021
Multitask Learning on Graph Convolutional Residual Neural Networks for Screening of Multitarget Anticancer Compounds
Thanh-Hoang Nguyen-Vo1, Trang T T Do1, Binh P Nguyen2
1Ho Chi Minh City Open University, 97 Vo Van Tan, District 3, Ho Chi Minh City 70000, Vietnam.
A new computational model, iACP-GCR, identifies multitarget anticancer compounds using graph convolutional residual neural networks. This approach accelerates the discovery of potential anticancer drugs by outperforming existing methods.
Area of Science:
- Computational chemistry
- Drug discovery
- Bioinformatics
Background:
- Experimental screening for anticancer drugs is time-consuming and resource-intensive.
- Computational methods are needed to accelerate the identification of potential anticancer compounds.
- Multitarget drug discovery aims to identify compounds effective against multiple cancer types.
Purpose of the Study:
- To develop an advanced computational model for identifying multitarget anticancer compounds.
- To improve the efficiency and accuracy of anticancer drug candidate screening.
- To provide a publicly accessible tool for researchers.
Main Methods:
- Utilized multitask learning on graph convolutional residual neural networks (GCRNs) with two shortcut connection types.
- Trained and evaluated the iACP-GCR model on the NCI-60 dataset, encompassing nine cancer types.
- Compared the model's performance against three advanced computational multitask learning methods.
Main Results:
- The iACP-GCR model demonstrated superior performance compared to existing advanced computational methods.
- The integration of dual shortcut connections enhanced prediction efficiency.
- The model successfully identified multitarget anticancer compounds with high accuracy.
Conclusions:
- iACP-GCR offers a powerful and efficient computational approach for anticancer drug discovery.
- The model's effectiveness in identifying multitarget compounds holds significant promise for cancer therapy.
- A public web server has been deployed to facilitate broader research community access and utilization.
More Related Videos
12:41Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...